Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd 2021 AR2
The report outlines Tianjin Zhong Xin Pharmaceutical Group's financial and operational performance for the fiscal year 2021, highlighting its transition under the mixed-ownership reform of its controlling shareholder, TPH. The company achieved a sales revenue of RMB 6,908 million, representing a 4.6% year-on-year increase, and a net profit of RMB 769 million. Key highlights include the inclusion of several flagship products like Suxiao Jiuxin Wan in national clinical guidelines and the recognition of its traditional processing techniques as National-level Intangible Cultural Heritage. The company also emphasizes its commitment to integrating social responsibility and sustainable development into its business operations.
Company: Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Sector: Health Care
Country: China
Year: 2021
Type: AR2
Pages: 212
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Annual Report
The report outlines Tianjin Zhong Xin Pharmaceutical Group's financial and operational performance for the fiscal year 2021, highlighting its transition under the mixed-ownership reform of its controlling shareholder, TPH. The company achieved a sales revenue of RMB 6,908 million, representing a 4.6% year-on-year increase, and a net profit of RMB 769 million. Key highlights include the inclusion of several flagship products like Suxiao Jiuxin Wan in national clinical guidelines and the recognition of its traditional processing techniques as National-level Intangible Cultural Heritage. The company also emphasizes its commitment to integrating social responsibility and sustainable development into its business operations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
No data available